Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860015 · ClinicalTrials.gov registry record · Phase 2
Alimta Plus Gemcitabine for Advanced Sarcoma
A Phase 2 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
NCT00860015 is a Phase 2 study that has completed, run by Columbia University. The registered enrollment target is 12 participants.
The verdict
NCT00860015, a Phase 2 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
Study Summary
In patients with unresectable soft tissue sarcoma, what is the response rate if treated with Alimta and gemcitabine?
Interventions
- DRUG Gemcitabine
- DRUG Alimta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2005-08 |
| Est. Completion | 2012-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00860015
The ClinicalTrials.gov registry entry for NCT00860015 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Gemcitabine is the first listed.
NCT00860015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00860015 about?
NCT00860015 is a clinical study titled "Alimta Plus Gemcitabine for Advanced Sarcoma". In patients with unresectable soft tissue sarcoma, what is the response rate if treated with Alimta and gemcitabine?
What is the current status of trial NCT00860015?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 2005-08. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00860015?
The interventions under investigation include: Gemcitabine (DRUG), Alimta (DRUG).
Who is sponsoring clinical trial NCT00860015?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.